SBC / revenue moved 2478 bp higher
SBC / revenue changed +2478 basis points from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
SBC / revenue changed +2478 basis points from the comparable as-filed period.
R&D / revenue changed +717 basis points from the comparable as-filed period.
Receivables / revenue changed -1946 basis points from the comparable as-filed period.
Operating cash-flow margin changed +1688 basis points from the comparable as-filed period.
Research & development changed -12.3% from the comparable as-filed period.
Stock-based compensation changed -12.0% from the comparable as-filed period.
Gross profit changed -136.2% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Cash & equivalents changed +4.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.